SPS COMMERCE INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SPS COMMERCE INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $58.20M | Feb 26, 2018 |
| FY2017 | Sep 30, 2017 | $56.15M | Feb 26, 2018 |
| FY2017 | Jun 30, 2017 | $54.28M | Feb 26, 2018 |
| FY2017 | Mar 31, 2017 | $51.93M | Feb 26, 2018 |
| FY2017 | Dec 31, 2016 | $51.06M | Feb 26, 2018 |
| FY2017 | Sep 30, 2016 | $49.28M | Feb 26, 2018 |
| FY2017 | Jun 30, 2016 | $47.35M | Feb 26, 2018 |
| FY2017 | Mar 31, 2016 | $45.60M | Feb 26, 2018 |
| FY2016 | Dec 31, 2015 | $42.35M | Feb 27, 2017 |
| FY2016 | Sep 30, 2015 | $40.35M | Feb 27, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $751.51M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $637.77M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $536.91M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $450.88M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $385.28M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $312.63M | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $72.73M | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | $70.93M | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | $68.53M | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | $66.93M | Feb 25, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $519.88M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $427.05M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $354.84M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $297.81M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $253.60M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $212.79M | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $48.82M | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | $47.67M | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | $44.83M | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | $45.57M | Feb 25, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $93.34M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $77.05M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $65.82M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $55.13M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $44.60M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $45.59M | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $9.16M | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | $8.94M | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | $8.80M | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | $6.81M | Feb 25, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $118.30M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $88.88M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $77.25M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $71.18M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $55.09M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $50.16M | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $10.76M | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | $10.93M | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | $9.33M | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | $7.38M | Feb 25, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.68M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $62.81M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $53.65M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $45.75M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $39.04M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $31.02M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $28.31M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $22.09M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $23.18M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $21.98M | Mar 15, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $178.79M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $157.40M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $132.30M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $100.05M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $112.89M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $88.56M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $71.79M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $55.02M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $31.05M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $18.77M | Mar 15, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.52M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $20.05M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $19.76M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $19.88M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $19.59M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $16.47M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $13.59M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $13.75M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $7.27M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $8.01M | Mar 15, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.03B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $823.84M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $672.91M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $615.85M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $526.46M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $447.44M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $386.12M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $339.74M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $298.37M | Feb 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $195.97M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $176.54M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $156.37M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $135.84M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $131.59M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $105.74M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $92.56M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $67.15M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $51.63M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $49.10M | Feb 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $973.89M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $854.69M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $667.48M | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | $537.07M | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | $484.26M | Feb 19, 2025 |
| FY2023 | Dec 31, 2020 | $420.72M | Feb 21, 2024 |
| FY2022 | Dec 31, 2019 | $354.88M | Feb 21, 2023 |
| FY2021 | Dec 31, 2018 | $318.97M | Feb 22, 2022 |
| FY2020 | Dec 31, 2017 | $288.11M | Feb 23, 2021 |
| FY2019 | Dec 31, 2016 | $257.77M | Feb 25, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $541.72M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $399.18M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $249.18M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $197.28M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $143.66M | Feb 21, 2023 |
| FY2022 | Dec 31, 2020 | $134.85M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $76.85M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $69.66M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $51.61M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $49.78M | Mar 15, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $429.44M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $336.10M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $259.05M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $193.22M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $138.09M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $93.49M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $48.97M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $15.26M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | ($8.61M) | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | ($33.74M) | Feb 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $151.36M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $241.02M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $219.08M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $162.89M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $207.55M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $149.69M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $179.25M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $133.86M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $123.13M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $115.88M | Feb 26, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Mar 15, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 25, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 37.52M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 37.66M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 36.82M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 36.16M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 36.01M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | 35.49M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | 34.86M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | 34.69M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | 17.13M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 17.08M | Feb 26, 2018 |